Skip to content

Treatment of hypothyroidism with ayurvedic medicine punarnavadi leha & Aragvadhadi kashaya

A Randomized Comparative Clinical Study To Evaluate The Efficacy Of Punarnavadi Leha & Argvadhadi Kashaya In The Management Of Dhatvagnimandya W.S.R To Hypothyroidism - NIL

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/08/072781
Enrollment
90
Registered
2024-08-20
Start date
Unknown
Completion date
Unknown
Last updated
2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E039- Hypothyroidism, unspecified

Interventions

None listed

Sponsors

Bhanu Priya Choudhary
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: a)Subjects having age between 18 to 60 years of either sex. b)Newly diagnosed patients of TSH level 5-10 mlU/l. c)Patients having any sign and symptom of Dhatwagnimandhya (Hypothyroidism) will be selected for the present study. d)Patient willing to sign the consent form. e)Patient is able to take the medicine properly and follow the Pathya -Apathya f)Patient not taking any other medicine for this disease.

Exclusion criteria

Exclusion criteria: a)Patients below 18 years and above 60 years of age. b)Patients having TSH level more than 10 or less than 5. c)Patients suffering from any other major acute/ systemic illness viz. Diabetes, HTN, liver disorders etc. d)Pregnant women and lactating mothers. e)Patients undergoing treatment for any other systemic illness.

Design outcomes

Primary

MeasureTime frame
Any changes in the value of serum TSH.Timepoint: 3 months

Secondary

MeasureTime frame
Assessment of changes in specific symptoms of Dhatwagnimandhya (Hypothyroidism).Timepoint: 3 months

Countries

India

Contacts

Public ContactBHANU PRIYA CHOUDHARY

Madan Mohan Malviya Govt Ayurveda College, Udaipur

drindusharma4@gmail.com7976972310

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026